Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03775044 · ClinicalTrials.gov registry record · NA

Assessment of Medherent Medication Management Device and Adherence Platform

A NA study of Medication Adherence and Mental Health Disorder, sponsored by Terrapin Pharmacy.

Active
Registry status
NA
Development phase
150
Enrollment target
1
Study location

NCT03775044 is a NA study of Medication Adherence and Mental Health Disorder that is active but no longer recruiting, run by Terrapin Pharmacy. The registered enrollment target is 150 participants, below the 1,654-participant average among 52 other Medication Adherence trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03775044, a NA study of Medication Adherence and Mental Health Disorder, is active but no longer recruiting, sponsored by Terrapin Pharmacy.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
150 participants
Enrollment target
1
Study location

Study Summary

This study uses a stepped wedge designs to estimate the effect of using the Medherent Medication Management Device on medication adherence for a population of 150 individuals who are diagnosed with serious mental illness.

Interventions

  • DEVICE Medherent Device

Study Locations (1)

Maryland

  • Terrapin Pharmacy - Annapolis

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2019-05-01
Est. Completion 2023-03-31
Phase NA

Sponsor

Terrapin Pharmacy

1 total trials

What the Registry Record Tells You About NCT03775044

The ClinicalTrials.gov registry entry for NCT03775044 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,654-participant average among 52 other Medication Adherence trials with a reported enrollment target (91% lower). The listed sponsor is Terrapin Pharmacy, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Medication Adherence appearing as the primary indexed condition, and to 1 intervention - of which Medherent Device is the first listed.

NCT03775044 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT03775044 about?

NCT03775044 is a clinical study titled "Assessment of Medherent Medication Management Device and Adherence Platform". This study uses a stepped wedge designs to estimate the effect of using the Medherent Medication Management Device on medication adherence for a population of 150 individuals who are diagnosed with serious mental illness.

What is the current status of trial NCT03775044?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2019-05-01. Estimated completion is 2023-03-31.

What conditions does trial NCT03775044 study?

This clinical trial studies the following conditions: Medication Adherence, Mental Health Disorder.

What interventions are being tested in trial NCT03775044?

The interventions under investigation include: Medherent Device (DEVICE).

Who is sponsoring clinical trial NCT03775044?

This trial is sponsored by Terrapin Pharmacy, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03775044 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Medication Adherence

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.